Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Update on the Role of PCSK9 in Atherosclerosis
Ece Yurtseven, Dilek Ural, Kemal Baysal, et al.
Journal of Atherosclerosis and Thrombosis (2020) Vol. 27, Iss. 9, pp. 909-918
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Mouse models of atherosclerosis in translational research
Iqra Ilyas, Peter J. Little, Zhiping Liu, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 11, pp. 920-939
Open Access | Times Cited: 63
PCSK9 Inhibition: From Current Advances to Evolving Future
Chunping Liu, Jing Chen, Huiqi Chen, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2972-2972
Open Access | Times Cited: 63
Lipid oxidation in pathophysiology of atherosclerosis: Current understanding and therapeutic strategies
Rahagir Salekeen, Abu Nasim Haider, Fouzia Akhter, et al.
International Journal of Cardiology Cardiovascular Risk and Prevention (2022) Vol. 14, pp. 200143-200143
Open Access | Times Cited: 43
Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy
Emrush Rexhaj, Sarah Bär, Rodrigo Soria, et al.
Atherosclerosis (2024) Vol. 392, pp. 117504-117504
Open Access | Times Cited: 9
The role of PCSK9 in heart failure and other cardiovascular diseases—mechanisms of action beyond its effect on LDL cholesterol
Mieczysław Dutka, Karolina Zimmer, Michał Ćwiertnia, et al.
Heart Failure Reviews (2024) Vol. 29, Iss. 5, pp. 917-937
Open Access | Times Cited: 9
PCSK9 and atherosclerosis: Looking beyond LDL regulation
Rosetta Ragusa, Giuseppina Basta, Danilo Neglia, et al.
European Journal of Clinical Investigation (2020) Vol. 51, Iss. 4
Open Access | Times Cited: 68
PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation
Aureli Luquero, Lina Badimón, María Borrell‐Pages
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 50
Insight into the Evolving Role of PCSK9
Mateusz Maligłówka, Michał Kosowski, Marcin Hachuła, et al.
Metabolites (2022) Vol. 12, Iss. 3, pp. 256-256
Open Access | Times Cited: 32
Quercetin alleviates atherosclerosis by suppressing oxidized LDL-induced senescence in plaque macrophage via inhibiting the p38MAPK/p16 pathway
Gang Luo, Lu Xiang, Lin Xiao
The Journal of Nutritional Biochemistry (2023) Vol. 116, pp. 109314-109314
Closed Access | Times Cited: 21
Comprehensive view of macrophage autophagy and its application in cardiovascular diseases
Wanqian Pan, Jun Zhang, Lei Zhang, et al.
Cell Proliferation (2023) Vol. 57, Iss. 1
Open Access | Times Cited: 21
Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets
Cristi L. Galindo, Saifur R. Khan, Xiangyu Zhang, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 12, pp. 1231-1245
Closed Access | Times Cited: 16
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?
Stanisław Surma, Amirhossein Sahebkar, Maciej Banach
Current Atherosclerosis Reports (2024)
Open Access | Times Cited: 6
Sex difference in circulating PCSK9 and its clinical implications
Fang Jia, Si-Fan Fei, Debing Tong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Effect of evolocumab on the progression of intraplaque neovascularization of the carotid based on contrast-enhanced ultrasonography (EPIC study): A prospective single-arm, open-label study
Ju Chen, Fa-Ming Zhao, Chengbin Lei, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 11
Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review
Hina Arsh, FNU Manoj Kumar, FNU Simran, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 2, pp. 899-908
Open Access | Times Cited: 4
Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice
Xueying Zhang, Qingqing Lu, Yanjie Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Ellagic acid ameliorates atherosclerosis by inhibiting PCSK9 through the modulation of FoxO3 and HNF1α
Litian Wang, Huai-Liu Yin, Ya-Min Jin, et al.
Nutrition (2025) Vol. 134, pp. 112717-112717
Closed Access
PCSK9 with a gain of function D374Y mutation aggravates atherosclerosis by inhibiting PPARα expression
Yan Cui, Xi Chen, Tuoluonayi Mijiti, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Research Progress of PCSK9 in Clinical Practice
艳丽 胡
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 200-207
Closed Access
PCSK9 in Vascular Aging and Age-Related Diseases
Dong Tan, Xin Yang, Jing Yang, et al.
Aging and Disease (2025)
Open Access
Towards a Mechanistic Understanding of Atherosclerosis Drug Design
Sudhanshu Kalantri, Ami P. Thakkar, Amisha Vora, et al.
(2025), pp. 801-857
Closed Access
Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review)
Shan Chong, Guangyan Mu, Xinan Cen, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 6
Open Access | Times Cited: 3
Early and Short-term Use of PCSK9-Inhibitors on Coronary Plaque Stability in Acute Coronary Syndrome
Hiroki Uehara, Takashi Kajiya, Masami Abe, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 3
Increase of PCSK9 expression in diabetes promotes VEGFR2 ubiquitination to inhibit endothelial function and skin wound healing
Jianjun Gao, Fang-Yuan Wu, Yujia Liu, et al.
Science China Life Sciences (2024)
Closed Access | Times Cited: 3
Low or oscillatory shear stress and endothelial permeability in atherosclerosis
Li Chen, Hua Qu, Bin Liu, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top